Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2432278 | Fish & Shellfish Immunology | 2013 | 8 Pages |
To investigate the interaction between white spot syndrome virus (WSSV)-VP37 and gill membrane proteins (GMPs) of Pacific white shrimp (Litopenaeus vannamei), the VP37 protein was expressed and purified, and a distinct 53 kDa VP37-binding protein band was identified in GMPs by virus overlay protein binding assay and GST pull-down assay. By electroelution, the VP37 binding protein was purified and identified as F1ATP synthase β (F1ATPase β) subunit by Mass Spectrometry. The purified F1ATPase β subunit was used to immunize BALB/C mice to produce monoclonal antibodies (Mabs). After cell fusion, sixteen hybridomas secreting Mabs against F1ATPase β subunit of L. vannamei were screened by enzyme-linked immunosorbant assay (ELISA), three of which designated as 1D5, 1E8 and 2H4 were cloned by limiting dilution and further characterized by indirect immunofluorescence assay (IIFA) and western blotting. The results of IIFA showed that specific fluorescence signals located at the peripheral zone of the gills of L. vannamei. Western blotting demonstrated that three Mabs reacted specifically with the 53 kDa protein band in GMPs of L. vannamei. By IIFA, the Mabs could also cross-react with the gill cells of three other WSSV-susceptible shrimps Fenneropenaeus chinensis, Penaeus monodon and Marsupenaeus japonicus. Furthermore, the three anti-F1ATPase β subunit Mabs could partially block the binding of WSSV to GMPs by ELISA in vitro, and also exhibited direct anti-WSSV activity in shrimp by neutralization assay in vivo. These findings suggested that F1ATPase β subunit involved in WSSV infection in L. vannamei.
► The binding interaction between VP37 and F1ATP synthase β subunit was identified. ► Monoclonal antibodies (MAbs) against F1ATPase β were produced and characterized. ► Anti-F1ATPase β Mabs could partially block the binding of WSSV to GMPs in vitro. ► Anti-F1ATPase β Mabs could partially block WSSV infection in vivo.